 |
|
|
| | | | | | Dear colleagues,
| | | | | | | | ISHL12 will feature sessions, workshops and seminars that will cover all relevant aspects of Hodgkin lymphoma research as well updates on current treatment strategies.
Cellular Therapies | | | | | | | | We are particularly excited to introduce a novel session on cellular therapies which will include an update on recent developments in this area covering both basic research and clinical application by world-leading experts. In this session, we will also discuss the implications of recent advances in the field on Hodgkin lymphoma.
Older and Frail Patients | | | | | | | | Another focus of ISHL12 will be on older and frail patients. While we have witnessed huge improvements in outcomes for younger patients in recent decades, older and frail patients still have markedly worse outcomes with contemporary treatment. At the same time, the numbers of patients in this particular population increases across the globe, rendering improvements in care for this population highly relevant.
| | | | | |
|
| | | | | | Abstract Submission and
Early Bird Registration | | | | | | | | The abstract submission and online registration for ISHL12 were opened recently. Early bird registration for both on site and virtual participation will end on May 31, 2022. To ensure a quick and correct processing of your registration information, please use the online registration.
| | | | | | | | Alternatively, you can contact our organizational team at info@hodgkinsymposium.org.
| | | | | |
|
| | | | | | ISHL12 will take place from October 22 to 24, 2022 in Cologne, Germany. Please visit our website for further information.
| | | | | |
|
| | | | | | All the best and stay safe!
| | | | | | | | | | | | |
|
|
|
